1. CONCLUSION Early Simvastatin treatment effectively improves the cardiac function in ACS patients in a dose - dependent manner.

2. CONCLUSION: Simvastatin can decrease lipidemia, associated to the proteinuria decrease and the protection of renal function.

3. Conclusions : Both fluvastatin and simvastatin have good efficacy and safety on the patients with primary hypercholesterolemia .

4. Simvastatin may effectively attenuate DN progression through down - regulating the expression of TGF - ? ? via p 38 MAPK.

5. Both simvastatin and CDPC can relieve the damages of the brain in rats HIBD.

6. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial.

7. Objective Observe the blood lipid-reducing efficacy of the simvastatin on earlier stage of primary hyperlipaemia and acute coronary syndrome and the affection of ischemia event.

8. AIM: To probe the efficacy of simvastatin for lowering lipidemia in diabetic nephropathy with hyperlipidemia and protecting renal function.

9. Simvastatin is sold as a single-ingredient generic medication and as the brand-name Zocor.

10. Objective:To observe the influence of simvastatin on plasma C-reactive protein (CRP) and matrix metalloprotein (MMP)-9 level in patients with acute coronary syndrome(ACS) within 3 days.

11. Objective To explore the effect of simvastatin on airway mucus hypersecretion in rats.

12. Objective To explore the therapeutic effect of simvastatin on the pulmonary hypertension induced by injected monocrotaline combining with high pulmonary blood flow of rats.

13. The study also confirmed that adding fenofibrate to simvastatin did not result in any excess risk of myopathy (muscle problems), venous thrombosis or pancreatitis.

14. Methods: Simvastatin was synthesized from lovastatin via several steps involving acetylization, methylation , hydrolytic decomposition and cyclization reactions.

15. The risk of myopathy is also increased when simvastatin, especially at the higher doses(), is used with certain drugs (see Simvastatin Dose Limitations below).

16. Objective To investigate the influences of simvastatin on carotid artery Intima - media thickness ( IMT ) and carotid atherosclerotic plaque.

17. Methods: Simvastatin was synthesized from lovastatin via acetylization, methylation, hydrolytic decomposition and cyclization reactions.

18. Objective: To study the effect of Simvastatin on the proliferation and mineralization of cultured rat calvaria osteoblasts (RCOBs).

19. Aim To compare the effects of different doses of simvastatin on decreasing blood-lipoids.

20. About 45% of the patients received antilymphocyte induction therapy for up to five days and pravastatin or simvastatin unless contraindicated .

21. OBJECTIVE To prepare sustained - release dropping pills of Simvastatin and optimize its preparation technology.

22. The over expression could be blocked by arecoline, PPVP, DMHPPP and simvastatin.

23. AIM To investigate the influences of polymorphism of cholesteryl ester transfer protein CETP gene I405V on the level of blood fat and the lipid lowing effect of simvastatin.

24. A method for analysis of butyl hydroxy anisole(BHA, antioxidant) in simvastatin had been established by HPLC.

25. I head for the kitchen and line up the pills he's supposed to be taking: the alpha-blocker for prostate, the blood-pressure meds, the simvastatin for high cholesterol, the vitamins, the baby aspirin.

26. Indeed, as we wrote here and here, Lipitor is already hurting because of competition from simvastatin, the generic version of Merck's Zocor.

27. The electron microscopy observation revealed that lipid deposition in the intima and subjacent media was marked in group B, but simvastatin improved these changes in group C.

28. Discuss with patients the benefits and risks, including the risk of myopathy and rhabdomyolysis, of simvastatin therapy.